Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,626.00p
   
  • Change Today:
    -80.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 2,234.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 61,717
  • Market Cap: 1,727.22m
  • RiskGrade: 128
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 566.00 71.11 82.60p 31.8 n/a -18% 30.10p 1.1%
30-Jun-23 616.00 83.12 96.00p 27.4 1.7 +16% 32.00p 1.2%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
30-Jun-2023 616 645 638 617 645 n/a
 
Earnings
30-Jun-2023 96.00p 98.17p 95.87p 93.77p 107.11p n/a
 
Dividend
30-Jun-2023 32.00p 35.37p 36.97p 35.01p 36.70p n/a
 
Recommendations
Strong Buy 2 2 2 4 4 4
Buy 0 0 0 0 0 1
Neutral 0 0 1 2 2 1
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 2 2 3 6 6 6
 
Average Rec 10.00 10.00 8.33 8.33 8.33 8.75

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,626.00p
Change Today -80.00p
% Change -2.96 %
52 Week High 6,070.00
52 Week Low 2,234.00
Volume 61,717
Shares Issued 65.77m
Market Cap 1,727.22m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.38% below the market average94.38% below the market average94.38% below the market average94.38% below the market average94.38% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Price Trend
70.13% below the market average70.13% below the market average70.13% below the market average70.13% below the market average70.13% below the market average
9.38% below the sector average9.38% below the sector average9.38% below the sector average9.38% below the sector average9.38% below the sector average
Income
86.81% below the market average86.81% below the market average86.81% below the market average86.81% below the market average86.81% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
40.64% above the market average40.64% above the market average40.64% above the market average40.64% above the market average40.64% above the market average
64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 17-Aug-2022

Time Volume / Share Price
17:11 37 @ 2,632.00p
16:37 5,468 @ 2,643.01p
16:37 59 @ 2,626.00p
16:35 27,588 @ 2,626.00p
16:29 31 @ 2,632.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page